Scarica l'app Stockscreener
14.64
5.96%
0.90
Precedente Chiudi:
$13.74
Aprire:
$13.97
Volume 24 ore:
379.01K
Relative Volume:
0.45
Capitalizzazione di mercato:
$4.12B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-12.82
EPS:
-1.142
Flusso di cassa netto:
-
1 W Prestazione:
+2.74%
1M Prestazione:
+22.65%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$13.95
$14.98
Intervallo di 1 settimana:
$13.73
$14.98
Portata 52W:
$10.65
$19.05
Minimed Group Inc Stock (MMED) Company Profile
Nome
Minimed Group Inc
Settore
Industria
Telefono
763-222-9423
Indirizzo
18000 DEVONSHIRE ST., NORTHRIDGE
Compare MMED vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MMED
Minimed Group Inc
|
14.65 | 3.86B | 0 | 0 | 0 | -1.142 |
ISRG
Intuitive Surgical Inc
|
403.42 | 142.79B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.71 | 39.66B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
68.24 | 32.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.90 | 29.85B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
196.09 | 27.74B | 5.54B | 1.52B | 1.74B | 10.37 |
Minimed Group Inc Stock (MMED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-31 | Iniziato | BTIG Research | Buy |
| 2026-03-31 | Iniziato | BofA Securities | Buy |
| 2026-03-31 | Iniziato | Citigroup | Buy |
| 2026-03-31 | Iniziato | Deutsche Bank | Buy |
| 2026-03-31 | Iniziato | Evercore ISI | Outperform |
| 2026-03-31 | Iniziato | Goldman | Buy |
| 2026-03-31 | Iniziato | Mizuho | Outperform |
| 2026-03-31 | Iniziato | Morgan Stanley | Overweight |
| 2026-03-31 | Iniziato | Piper Sandler | Neutral |
| 2026-03-31 | Iniziato | Wells Fargo | Overweight |
| 2026-03-31 | Iniziato | William Blair | Outperform |
Mostra tutto
Minimed Group Inc Borsa (MMED) Ultime notizie
MiniMed rolls out Abbott’s 15-day Instinct sensors across Europe - Stock Titan
This Undervalued Medical-Devices Stock Is Poised for a Rebound - Barron's
MiniMed Group (MMED) Stock Forecast and Price Target 2026 - MarketBeat
A Quick Look at Today's Ratings for MiniMed Group(MMED.US), With a Forecast Between $16 to $25 - Moomoo
Is Medtronic's MiniMed Spin-Off a Smart Bet for Investors - Kavout
MiniMed’s smallest insulin pump is now on sale in the U.S. - Stock Titan
William Blair Initiates MiniMed Group(MMED.US) With Buy Rating - Moomoo
MMED Q1 2026 Earnings: EPS Falls Far Short of EstimatesLow Growth Earnings - newsline.com
Benchmark reiterates MiniMed Group stock rating on product launches By Investing.com - Investing.com Canada
MMED Price Today: MiniMed Group, Inc. Stock Price, Quote & Chart | MEXC - MEXC
MMED's latest study supports the strength of 780G SmartGuard algorithm - MSN
Wells Fargo Maintains MiniMed Group(MMED.US) With Buy Rating, Raises Target Price to $26 - Moomoo
MiniMed Group (MMED) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
MiniMed Group Inc. (MMED) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
A Look At MiniMed Group (MMED) Valuation After Recent Share Price Volatility - Yahoo Finance
MiniMed Group (MMED) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
BofA Securities Maintains MiniMed Group(MMED.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Evercore Maintains MiniMed Group(MMED.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Piper Sandler reiterates Neutral rating on MiniMed stock at $16 - Investing.com
Piper Sandler reiterates Neutral rating on MiniMed stock at $16 By Investing.com - Investing.com India
MiniMed Fiscal Q4 Loss Unchanged, Revenue Rises; Shares Up Pre-Bell - Moomoo
MiniMed Closes FY26 On A Strong Note, Eyes Long-Term Growth - RTTNews
MiniMed (MMED) Reports Strong Q4 Revenue Growth - GuruFocus
Minimed Group Inc (MMED) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Product ... By GuruFocus - Investing.com Canada
MMED Projects 16% Adjusted EBITDA Margin by FY27 - GuruFocus
Why Medtronic Stock Popped Today - Yahoo Finance
MiniMed Group Inc. (MMED) Surges 12.93% as Bulls Test Key Resistance LevelStock Buy Zone - newsline.com
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday - Benzinga
MiniMed Stock Surges 11% to $13.69 After Strong Q4 Results and Bullish 2027 Outlook - International Business Times Australia
MMED: Record revenue, robust pipeline, and 10% organic growth outlook for FY 2027 - TradingView
Earnings call transcript: MiniMed sees strong Q4 2026 growth, stock rises By Investing.com - Investing.com South Africa
MiniMed Group Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: MiniMed sees strong Q4 2026 growth, stock rises - Investing.com
MMED: Record revenue, robust pipeline, and 10% growth outlook highlight strong momentum - TradingView
MiniMed Shares Rise on 4Q Sales, Abbott Partnership Expansion - marketscreener.com
Full Transcript: Minimed Group Q4 2026 Earnings Call - Benzinga
MiniMed Group Q4 2026 Earnings Call Transcript - MarketBeat
MiniMed Group, Inc. Reports Earnings Results for the Fourth Quarter Ended April 24, 2026 - marketscreener.com
Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years - Medtronic
MMED: FY26 revenue surpassed $3B with strong growth and FY27 guidance targets further margin expansion - TradingView
Minimed: Fiscal Q4 Earnings Snapshot - marketscreener.com
Earnings Flash (MMED) MiniMed Reports Q4 Revenue $837.0M, vs. FactSet Est of $827.9M - marketscreener.com
MiniMed partners with Abbott on dual glucose-ketone sensors By Investing.com - Investing.com Canada
MMED: Record $3B+ sales, strong international growth, and FY27 guidance for 10% organic revenue growth - TradingView
MiniMed (MMED) grows revenue to $3.1B in FY 2026 but widens loss - Stock Titan
MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott - marketscreener.com
MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook - marketscreener.com
New diabetes sensor tracks ketones to spot DKA risk earlier - Stock Titan
Diabetes tech firm MiniMed tops $3.1B sales, sees 10% organic growth in FY27 - Stock Titan
Minimed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott - marketscreener.com
Minimed Group Inc Azioni (MMED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):